The American Society of Hematology (ASH) has announced that their draft recommendations on Frontline Management and Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults (AYAs) are now open for public comment. These guidelines have been developed to assist healthcare practitioners in the treatment and management of ALL in AYA patients.
The ASH guidelines development process involves a comprehensive evaluation by a panel of experts who analyze the evidence and develop recommendations. The public comment period provides an opportunity for stakeholders to provide feedback on the recommendations before the guidelines are finalized.
ASH welcomes all interested parties to review and provide feedback here prior to society approval and publication. Comments will be accepted until October 29, 2024. Your input is valuable in shaping the future of ALL management.
Copyright © 2024 Guideline Central, All Rights Reserved.